These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20051807)

  • 1. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.
    Carbone A; Cesarman E; Gloghini A; Drexler HG
    AIDS; 2010 Feb; 24(4):479-90. PubMed ID: 20051807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus.
    Arvanitakis L; Mesri EA; Nador RG; Said JW; Asch AS; Knowles DM; Cesarman E
    Blood; 1996 Oct; 88(7):2648-54. PubMed ID: 8839859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.
    Sanchez-Martin D; Uldrick TS; Kwak H; Ohnuki H; Polizzotto MN; Annunziata CM; Raffeld M; Wyvill KM; Aleman K; Wang V; Marshall VA; Whitby D; Yarchoan R; Tosato G
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.
    Gloghini A; Volpi CC; Gualeni AV; Dolcetti R; Bongarzone I; De Paoli P; Carbone A
    Expert Rev Hematol; 2017 Jun; 10(6):505-514. PubMed ID: 28468596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
    Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
    PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
    Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival.
    Wang C; Zhu C; Wei F; Zhang L; Mo X; Feng Y; Xu J; Yuan Z; Robertson E; Cai Q
    J Virol; 2015 Oct; 89(20):10416-26. PubMed ID: 26246572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression Ratios of the Antiapoptotic BCL2 Family Members Dictate the Selective Addiction of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Primary Effusion Lymphoma Cell Lines to MCL1.
    Dunham D; Viswanathan P; Gill J; Manzano M
    J Virol; 2022 Dec; 96(23):e0136022. PubMed ID: 36416587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells.
    Haddad L; El Hajj H; Abou-Merhi R; Kfoury Y; Mahieux R; El-Sabban M; Bazarbachi A
    Leukemia; 2008 Apr; 22(4):826-34. PubMed ID: 18094712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL).
    Dai L; Trillo-Tinoco J; Bai L; Kang B; Xu Z; Wen X; Del Valle L; Qin Z
    PLoS One; 2014; 9(2):e90349. PubMed ID: 24587336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.
    Gottwein E; Corcoran DL; Mukherjee N; Skalsky RL; Hafner M; Nusbaum JD; Shamulailatpam P; Love CL; Dave SS; Tuschl T; Ohler U; Cullen BR
    Cell Host Microbe; 2011 Nov; 10(5):515-26. PubMed ID: 22100165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
    Zhang YJ; Patel D; Nan Y; Fan S
    Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma.
    Goto H; Kariya R; Kudo E; Katano H; Okada S
    Neoplasia; 2024 Oct; 56():101035. PubMed ID: 39096792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
    Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
    Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas.
    Uphoff CC; Carbone A; Gaidano G; Drexler HG
    Leukemia; 1998 Nov; 12(11):1806-9. PubMed ID: 9823957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
    Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
    J Virol; 2020 May; 94(10):. PubMed ID: 32161170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.